186 related articles for article (PubMed ID: 15759036)
1. Regulation of glucocorticoid receptor steroid binding and trafficking by the hsp90/hsp70-based chaperone machinery: implications for clinical intervention.
Murphy PJ
Leukemia; 2005 May; 19(5):710-2. PubMed ID: 15759036
[No Abstract] [Full Text] [Related]
2. mRNA expression levels of (co)chaperone molecules of the glucocorticoid receptor are not involved in glucocorticoid resistance in pediatric ALL.
Tissing WJ; Meijerink JP; den Boer ML; Brinkhof B; Pieters R
Leukemia; 2005 May; 19(5):727-33. PubMed ID: 15759037
[TBL] [Abstract][Full Text] [Related]
3. Cofactor Tpr2 combines two TPR domains and a J domain to regulate the Hsp70/Hsp90 chaperone system.
Brychzy A; Rein T; Winklhofer KF; Hartl FU; Young JC; Obermann WM
EMBO J; 2003 Jul; 22(14):3613-23. PubMed ID: 12853476
[TBL] [Abstract][Full Text] [Related]
4. Heat shock protein 90 is an essential molecular chaperone for nuclear transport of glucocorticoid receptor beta.
Zhang X; Clark AF; Yorio T
Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):700-8. PubMed ID: 16431970
[TBL] [Abstract][Full Text] [Related]
5. Nucleophosmin-anaplastic lymphoma kinase (NPM-ALK), a novel Hsp90-client tyrosine kinase: down-regulation of NPM-ALK expression and tyrosine phosphorylation in ALK(+) CD30(+) lymphoma cells by the Hsp90 antagonist 17-allylamino,17-demethoxygeldanamycin.
Bonvini P; Gastaldi T; Falini B; Rosolen A
Cancer Res; 2002 Mar; 62(5):1559-66. PubMed ID: 11888936
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of the hsp70-binding protein BAG-1 on glucocorticoid receptor folding by the hsp90-based chaperone machinery.
Kanelakis KC; Morishima Y; Dittmar KD; Galigniana MD; Takayama S; Reed JC; Pratt WB
J Biol Chem; 1999 Nov; 274(48):34134-40. PubMed ID: 10567384
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling of human colon cancer cells following inhibition of signal transduction by 17-allylamino-17-demethoxygeldanamycin, an inhibitor of the hsp90 molecular chaperone.
Clarke PA; Hostein I; Banerji U; Stefano FD; Maloney A; Walton M; Judson I; Workman P
Oncogene; 2000 Aug; 19(36):4125-33. PubMed ID: 10962573
[TBL] [Abstract][Full Text] [Related]
8. [Heat shock protein 90: novel target for cancer therapy].
Chen Y; Ding J
Ai Zheng; 2004 Aug; 23(8):968-74. PubMed ID: 15301726
[TBL] [Abstract][Full Text] [Related]
9. Abrogation of heat shock protein 70 induction as a strategy to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycin.
Guo F; Rocha K; Bali P; Pranpat M; Fiskus W; Boyapalle S; Kumaraswamy S; Balasis M; Greedy B; Armitage ES; Lawrence N; Bhalla K
Cancer Res; 2005 Nov; 65(22):10536-44. PubMed ID: 16288046
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of glucocorticoid resistance in human leukemic cells: implication of abnormal 90 and 70 kDa heat shock proteins.
Kojika S; Sugita K; Inukai T; Saito M; Iijima K; Tezuka T; Goi K; Shiraishi K; Mori T; Okazaki T; Kagami K; Ohyama K; Nakazawa S
Leukemia; 1996 Jun; 10(6):994-9. PubMed ID: 8667658
[TBL] [Abstract][Full Text] [Related]
11. Stable and specific binding of heat shock protein 90 by geldanamycin disrupts glucocorticoid receptor function in intact cells.
Whitesell L; Cook P
Mol Endocrinol; 1996 Jun; 10(6):705-12. PubMed ID: 8776730
[TBL] [Abstract][Full Text] [Related]
12. The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins.
Connell P; Ballinger CA; Jiang J; Wu Y; Thompson LJ; Höhfeld J; Patterson C
Nat Cell Biol; 2001 Jan; 3(1):93-6. PubMed ID: 11146632
[TBL] [Abstract][Full Text] [Related]
13. hsp70 interacting protein Hip does not affect glucocorticoid receptor folding by the hsp90-based chaperone machinery except to oppose the effect of BAG-1.
Kanelakis KC; Murphy PJ; Galigniana MD; Morishima Y; Takayama S; Reed JC; Toft DO; Pratt WB
Biochemistry; 2000 Nov; 39(46):14314-21. PubMed ID: 11087380
[TBL] [Abstract][Full Text] [Related]
14. Geldanamycin, a heat shock protein 90-binding benzoquinone ansamycin, inhibits steroid-dependent translocation of the glucocorticoid receptor from the cytoplasm to the nucleus.
Czar MJ; Galigniana MD; Silverstein AM; Pratt WB
Biochemistry; 1997 Jun; 36(25):7776-85. PubMed ID: 9201920
[TBL] [Abstract][Full Text] [Related]
15. ErbB2 degradation mediated by the co-chaperone protein CHIP.
Zhou P; Fernandes N; Dodge IL; Reddi AL; Rao N; Safran H; DiPetrillo TA; Wazer DE; Band V; Band H
J Biol Chem; 2003 Apr; 278(16):13829-37. PubMed ID: 12574167
[TBL] [Abstract][Full Text] [Related]
16. Animal and plant cell lysates share a conserved chaperone system that assembles the glucocorticoid receptor into a functional heterocomplex with hsp90.
Stancato LF; Hutchison KA; Krishna P; Pratt WB
Biochemistry; 1996 Jan; 35(2):554-61. PubMed ID: 8555227
[TBL] [Abstract][Full Text] [Related]
17. Heat shock protein 90 inhibition by 17-allylamino-17- demethoxygeldanamycin: a novel therapeutic approach for treating hormone-refractory prostate cancer.
Neckers L
Clin Cancer Res; 2002 May; 8(5):962-6. PubMed ID: 12006507
[No Abstract] [Full Text] [Related]
18. Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery.
Pratt WB; Toft DO
Exp Biol Med (Maywood); 2003 Feb; 228(2):111-33. PubMed ID: 12563018
[TBL] [Abstract][Full Text] [Related]
19. Chaperone Activity and Dimerization Properties of Hsp90
Morishima Y; Mehta RK; Yoshimura M; Lau M; Southworth DR; Lawrence TS; Pratt WB; Nyati MK; Osawa Y
Mol Pharmacol; 2018 Sep; 94(3):984-991. PubMed ID: 29941666
[TBL] [Abstract][Full Text] [Related]
20. Hsp110 chaperones control client fate determination in the hsp70-Hsp90 chaperone system.
Mandal AK; Gibney PA; Nillegoda NB; Theodoraki MA; Caplan AJ; Morano KA
Mol Biol Cell; 2010 May; 21(9):1439-48. PubMed ID: 20237159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]